Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

2.85
Delayed Data
As of 11:49am ET
 +0.11 / +4.01%
Today’s Change
1.63
Today|||52-Week Range
26.25
+41.09%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close2.74
Today’s open2.67
Day’s range2.67 - 2.88
Volume2,149
Average volume (3 months)29,024
Market cap$25.1M
Dividend yield--
Data as of 11:49am ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+78.08%
Earnings growth (next 5 years)--
Revenue growth (last year)+315.65%
P/E ratioNM
Price/Sales1.28
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PARNParnell Pharmaceutic...+0.02+1.44%
SBOTStellar Biotechnolog...+0.03+0.96%
VKTXViking Therapeutics ...+0.02+1.56%
OGENOragenics Inc+0.02+3.32%
Data as of 11:54am ET, 05/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$4.4M
Annual profit (last year)-$19.0M
Net profit margin-433.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer, Secretary &
Treasurer
Tom Paulson
Corporate headquarters
Emeryville, California

Forecasts

Partner Offers

Search for Jobs